Open Access
Med Sci (Paris)
Volume 35, Number 5, Mai 2019
Page(s) 467 - 469
Section M/S Revues
Published online 22 May 2019
  1. Hay M, Thomas DW, Craighead JL, et al. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014 ; 32 : 40–51. [CrossRef] [PubMed] [Google Scholar]
  2. Davis C, Naci H, Gurpinar E, et al. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European medicines agency: retrospective cohort study of drug approvals 2009–13. BMJ. 2017 ; 359 : j4530. [Google Scholar]
  3. Saglam-Metiner P, Gulce-Iz S, Biray-Avci C. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment. Gene. 2019 ; 686 : 203–212. [Google Scholar]
  4. Liu Z, Tang M, Zhao J, et al. Looking into the future: toward advanced 3D biomaterials for stem-cell-based regenerative medicine. Adv Mater. 2018 ; 30 : e1705388. [CrossRef] [PubMed] [Google Scholar]
  5. Wan ACA. Recapitulating cell-cell interactions for organoid construction - Are biomaterials dispensable?. Trends Biotechnol. 2016 ; 34 : 711–721. [CrossRef] [PubMed] [Google Scholar]
  6. Clement B, Chene G, Degos F. A national collection of liver tumours: lessons learnt from 6 years of biobanking in France. Cancer Lett. 2009 ; 286 : 140–144. [Google Scholar]
  7. Gagliardi G. Ben M’Barek K, Goureau O. Photoreceptor cell replacement in macular degeneration and retinitis pigmentosa: A pluripotent stem cell-based approach. Prog Retin Eye Res. 2019 ; 10.1016/j.preteyeres.2019.03.001 [CrossRef] [PubMed] [Google Scholar]
  8. Mahe MM, Aihara E, Schumacher MA, et al. Establishment of gastrointestinal epithelial organoids. Curr Protoc Mouse Biol. 2013 ; 3 : 217–240. [CrossRef] [PubMed] [Google Scholar]
  9. Picollet-D’hahan N, Dolega ME, Freida D, et al. Deciphering cell intrinsic properties: a key issue for robust organoid production. Trends Biotechnol 2017; 35 : 1035–48. [CrossRef] [PubMed] [Google Scholar]
  10. Rabesandratana O, Goureau O, Orieux G. Pluripotent stem cell-based approaches to explore and treat optic neuropathies. Front Neurosci. 2018 ; 12 : 651. [Google Scholar]
  11. Sebert M, Denadai-Souza A, Quaranta M, et al. Thrombin modifies growth, proliferation and apoptosis of human colon organoids: a protease-activated receptor 1- and protease-activated receptor 4-dependent mechanism. Br J Pharmacol. 2018 ; 175 : 3656–3668. [CrossRef] [PubMed] [Google Scholar]
  12. Steichen C, Si-Tayeb K, Wulkan F, et al. Human induced pluripotent stem (hiPS) cells from urine samples: A non-integrative and feeder-free reprogramming strategy. Curr Protoc Hum Genet 2017; 92 : 21.7.1–21.7.22. [Google Scholar]
  13. Watanabe M, Buth JE, Vishlaghi N, et al. Self-organized cerebral organoids with human-specific features predict effective drugs to combat Zika virus infection. Cell Rep. 2017 ; 21 : 517–532. [CrossRef] [PubMed] [Google Scholar]
  14. Drost J, Clevers H. Organoids in cancer research. Nat Rev Cancer. 2018 ; 18 : 407–418. [Google Scholar]
  15. Dekkers JF, Berkers G, Kruisselbrink E, et al. Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis. Sci Transl Med 2016; 8 : 344ra84. [CrossRef] [PubMed] [Google Scholar]
  16. Bian S, Repic M, Guo Z, et al. Genetically engineered cerebral organoids model brain tumor formation. Nat Methods. 2018 ; 15 : 631–639. [CrossRef] [PubMed] [Google Scholar]
  17. Chakradhar S.. Put to the test: Organoid-based testing becomes a clinical tool. Nat Med. 2017 ; 23 : 796–799. [CrossRef] [PubMed] [Google Scholar]
  18. Hafner S.. Compétition iGEM 2008; deux équipes françaises !. Med Sci (Paris). 2009 ; 25 : 524–528. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  19. Briand W, Dao O, Garnier G, et al. Compétition IGEM 2018: une médaille d’or pour l’équipe GO Paris-Saclay. Med Sci (Paris). 2018 ; 34 : 1111–1114. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  20. Kelwick R, Bowater L, Yeoman KH, Bowater RP. Promoting microbiology education through the iGEM synthetic biology competition. FEMS Microbiol Lett 2015; 362. pii: fnv129. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.